Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

Reusser, P

doi:10.1182/blood.v99.4.1159

Public

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

Published in Blood • Feb 15, 2002

Authors:

P Reusser

Abstract

The present study compared foscarnet with ganciclovir for preemptive therapy of cytomegalovirus (CMV) infection after allogeneic blood or marrow stem cell transplantation (SCT). Patients with CMV infection, as detected by weekly antigenemia or polymerase chain reaction (PCR) in blood leukocytes, wer...

Subject

Foscarnet

Ganciclovir

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!